VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
YESID ALVARADO
Concepts (296)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Academic Medical Centers
Acute Disease
Acute Kidney Injury
Adenine
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Aminoglycosides
Anemia
Anemia, Aplastic
Animals
Anti-Bacterial Agents
Antibiotics, Antineoplastic
Antibodies, Bispecific
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antifungal Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Antiviral Agents
Arabinonucleosides
Arsenicals
Arthralgia
Atrial Fibrillation
Autoantibodies
Autoimmune Diseases
Azacitidine
Azoles
Bacterial Infections
Bacterial Toxins
Benzamides
Benzimidazoles
Benzoates
Benzothiazoles
Biomarkers
Biomarkers, Tumor
Biopsy
Blast Crisis
Blood Platelets
Blood Transfusion
Bone Marrow
Bone Marrow Cells
Bridged Bicyclo Compounds, Heterocyclic
Bronchial Spasm
Burkitt Lymphoma
Cancer Care Facilities
Carbazoles
Carbolines
Cardiovascular Diseases
Cell Cycle Proteins
Cell Lineage
Chemistry, Pharmaceutical
Chromosome Aberrations
Chromosomes, Human, Pair 22
Chromosomes, Human, Pair 9
Cladribine
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cohort Studies
Colitis
Combined Modality Therapy
Consolidation Chemotherapy
Constipation
Core Binding Factors
Cyclophosphamide
Cytarabine
Cytogenetic Analysis
Dasatinib
Daunorubicin
Deoxyadenine Nucleotides
Deoxyguanine Nucleotides
Dexamethasone
Diagnosis, Differential
Disease Management
Disease Progression
Disease-Free Survival
DNA
DNA Methylation
DNA Mutational Analysis
DNA, Neoplasm
Dose-Response Relationship, Drug
Doxorubicin
Drug Administration Schedule
Drug Combinations
Drug Delivery Systems
Drug Design
Drug Evaluation
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Drug Substitution
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Drugs, Investigational
Enzyme Inhibitors
Erlotinib Hydrochloride
Exanthema
Exotoxins
Factor VIII
Fatigue
Febrile Neutropenia
Female
Flow Cytometry
fms-Like Tyrosine Kinase 3
Folic Acid Antagonists
Follow-Up Studies
Furans
Fusion Proteins, bcr-abl
Gastrointestinal Diseases
Gene Expression Regulation, Neoplastic
Gene Frequency
Genes, abl
Genes, ras
Genetic Predisposition to Disease
Genomics
Geriatric Assessment
Germ-Line Mutation
Glucosides
Glutamates
Glycine
Graft vs Host Disease
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Granuloma, Plasma Cell
GRB2 Adaptor Protein
Guanine
Hearing Loss, Sudden
Heart
Hematinics
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Hemophilia A
Hemorrhage
Hepatic Veno-Occlusive Disease
Heterocyclic Compounds, 4 or More Rings
Humans
Hydrazines
Hypertension, Pulmonary
Idarubicin
Imatinib Mesylate
Imidazoles
Immunophenotyping
Immunosuppressive Agents
Immunotherapy
IMP Dehydrogenase
In Situ Hybridization, Fluorescence
Induction Chemotherapy
Infection Control
Infusions, Intravenous
Interferon-alpha
Isocitrate Dehydrogenase
Janus Kinase 1
Janus Kinase 2
Kaplan-Meier Estimate
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Acute
Leukemia, Myeloid, Chronic-Phase
Leukemia, Myelomonocytic, Chronic
Leukemia, Promyelocytic, Acute
Leukocyte Count
Li-Fraumeni Syndrome
Liver
Lung
Lung Diseases
Lung Neoplasms
Lymphocyte Count
Maintenance Chemotherapy
Male
Maximum Tolerated Dose
Medical Records
Methotrexate
Mice
Microtubules
Middle Aged
Molecular Targeted Therapy
Mouth Mucosa
Multicenter Studies as Topic
Mutation
Myelodysplastic Syndromes
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Myocardium
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasm, Residual
Neoplasms
Neoplasms, Second Primary
Neutropenia
Niacinamide
Nitriles
Nuclear Proteins
Nucleosides
Obesity
Oligodeoxyribonucleotides
Oncogene Proteins v-abl
Oxides
Partial Thromboplastin Time
Patient Safety
Patient Selection
Pedigree
Pemetrexed
Phenotype
Phenylurea Compounds
Philadelphia Chromosome
Phosphatidylinositol 3-Kinases
Pilot Projects
Piperazines
Piperidines
Platelet Count
Pneumonia
Point Mutation
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerases
Polyethylene Glycols
Polypharmacy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Primary Myelofibrosis
Prognosis
Programmed Cell Death 1 Receptor
Propensity Score
Proportional Hazards Models
Prospective Studies
Protein Isoforms
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-abl
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-bcr
Proto-Oncogene Proteins c-pim-1
Pyrazoles
Pyridazines
Pyridines
Pyrimidines
Recombinant Proteins
Recurrence
Remission Induction
Respiratory Insufficiency
Retrospective Studies
Ribonucleotide Reductases
Risk
Risk Factors
Rituximab
RNA-Binding Proteins
Safety
Salvage Therapy
Sarcoma
Sepsis
Serine-Arginine Splicing Factors
Sialic Acid Binding Ig-like Lectin 2
Signal Transduction
Single-Blind Method
Sirolimus
Skin
Spleen
Splicing Factor U2AF
Steroids
Stomatitis
Sulfonamides
Sulfones
Survival Analysis
Survival Rate
Texas
Thiazoles
Thiosemicarbazones
Thrombocytopenia
Thrombocytosis
Thrombosis
Time Factors
TOR Serine-Threonine Kinases
Transcription Factor RelA
Transcription Factors
Translocation, Genetic
Treatment Failure
Treatment Outcome
Tretinoin
Troponin I
Tumor Suppressor Protein p53
Uridine
Vidarabine
Vincristine
Virus Diseases
Young Adult
ALVARADO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (296)
Derived automatically from this person's publications.
Leukemia, Myeloid, Acute
Bridged Bicyclo Compounds, Heterocyclic
Myelodysplastic Syndromes
Sulfonamides
Antineoplastic Combined Chemotherapy Protocols
Explore
_
Co-Authors (64)
People in Profiles who have published with this person.
KANTARJIAN, HAGOP M
GARCIA-MANERO, GUILLERMO
JABBOUR, ELIAS JOSEPH
DINARDO, COURTNEY
KADIA, TAPAN MAHENDRA
Explore
_
Similar People (60)
People who share similar concepts with this person.
KANTARJIAN, HAGOP M
GARCIA-MANERO, GUILLERMO
JABBOUR, ELIAS JOSEPH
CORTES, JORGE E
KONOPLEVA, MARINA
Explore
_
Same Department
People who are also in this person's primary department.
BATTULA, VENKATA LOKESH
COLLA, SIMONA
FERRAJOLI, ALESSANDRA
KONOPLEVA, MARINA
YILMAZ, MUSA
Explore
_